Article
Bioactive Cycloperoxides Isolated from the Puerto Rican Sponge Plakortis halichondrioides.
Department of Chemistry, University of Puerto Rico, P.O. Box 23346, UPR Station, San Juan, Puerto Rico 00931-3346, and Department of Molecular Medicine, Beckman Research Institute, City of Hope, 500 East Duarte Road, Duarte, California 91010, United States.
Journal of Natural Products (impact factor:
3.13).
10/2010;
DOI:10.1021/np100461t
Source: PubMed
-
Citations (0)
- Cited In (2)
-
Article: Recent advances in antitubercular natural products.
[show abstract] [hide abstract]
ABSTRACT: Currently, one third of the world's population is infected with Mycobacterium tuberculosis and 8.9-9.9 million new and relapse cases of tuberculosis are reported every year. The emergence of new cases, the increased incidence of multi-drug resistant strains of M. tuberculosis, and the adverse effects of first- and second-line antituberculosis drugs have led to renewed research interest in natural products in the hope of discovering new antitubercular leads. Interestingly, hundreds of natural products, possessing novel, uncommon, and known structural architectures, have been reported to exhibit activity towards non-resistant and multi-drug resistant strains of M. tuberculosis. The present review covers literature published during the last five years about those naturally occurring compounds with reported growth inhibitory activity in vitro towards sensitive and resistant M. tuberculosis strains. Compounds with antitubercular properties at minimal inhibitory concentrations (MICs) of less than 50 μg/mL or 60 μM were selected and grouped according to their source of origin (plants, bacteria, fungi, marine organisms, etc) and chemical type (terpenes, steroids, alkaloids, flavonoids, poliketides, peptides, etc). In some cases, the selection covers those structurally relevant natural products with low bioactivity (MICs of ≤128 μg/mL), and also those semisynthetic derivatives with remarkable antitubercular activity (MICs of ≤10 μg/mL). Additionally, this review includes a special section for those natural products that specifically target genes or enzymes of M. tuberculosis.European journal of medicinal chemistry 03/2012; 49:1-23. · 3.27 Impact Factor -
Article: Antiplasmodial Natural Products
[show abstract] [hide abstract]
ABSTRACT: Malaria is a human infectious disease that is caused by four species of Plasmodium. It is responsible for more than 1 million deaths per year. Natural products contain a great variety of chemical structures and have been screened for antiplasmodial activity as potential sources of new antimalarial drugs. This review highlights studies on natural products with antimalarial and antiplasmodial activity reported in the literature from January 2009 to November 2010. A total of 360 antiplasmodial natural products comprised of terpenes, including iridoids, sesquiterpenes, diterpenes, terpenoid benzoquinones, steroids, quassinoids, limonoids, curcubitacins, and lanostanes; flavonoids; alkaloids; peptides; phenylalkanoids; xanthones; naphthopyrones; polyketides, including halenaquinones, peroxides, polyacetylenes, and resorcylic acids; depsidones; benzophenones; macrolides; and miscellaneous compounds, including halogenated compounds and chromenes are listed in this review.Molecules. 01/2011;
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
alcohols
antimalarial
antitubercular activity
compounds 3
cytotoxic activity
degradation reactions
epiplakinic acid F methyl ester
Kishi's method
new five-membered-ring polyketide endoperoxides
new metabolites
pathogenic microbes Plasmodium falciparum
plakortolide J
Puerto Rican sponge Plakortis halichondrioides
semisynthetic analogues 7-12
spectroscopic
strong activity
various human tumor cell lines